BioNTech SE(BNTX) - 2024 Q1 - Earnings Call Transcript

We are in the planning phase with our partner Genmab, so that we cannot disclose any specifics at this time. But you will hear more about this program sometime later this year. Operator Hi, Daina. So we have at the moment the clinical trial running in multiple indications, including also indications for single arm and combination. What we are going to update is -- on ASCO is on the cervical cancer and platinum-resistant ovarian cancer, and non-small-cell lung cancer trials. And you will see response data an ...